0001641172-25-001922.txt : 20250331 0001641172-25-001922.hdr.sgml : 20250331 20250331191750 ACCESSION NUMBER: 0001641172-25-001922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seshadri Vishwas CENTRAL INDEX KEY: 0001865131 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 25795931 MAIL ADDRESS: STREET 1: 64 STRYKER COURT CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR CITY: CLEVELAND STATE: OH ZIP: 44103 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR CITY: CLEVELAND STATE: OH ZIP: 44103 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2025-03-31 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001865131 Seshadri Vishwas 6555 CARNEGIE AVE., 4TH FLOOR CLEVELAND OH 44103 1 1 0 0 Chief Executive Officer 1 Common Stock 2025-03-31 4 S 0 25000 4.78 D 1355322 D The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.81 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. /s/ Vishwas Seshadri 2025-03-31